MYD88 and systemic lupus erythematosus: In contrast to the central role of MyD88 in the signaling process, only promising in vitro results are available for the MyD88 inhibitor, TJ-M2010-5, which was able to reduce the activation of lupus-like B cells by preventing proliferation and antibody production (42).